本頁面由Tiger Trade Technology Pte. Ltd.提供服務

4D Molecular Therapeutics

13.17
-0.3200-2.37%
盤後13.170.00000.00%19:56 EDT
成交量:48.12萬
成交額:634.48萬
市值:7.28億
市盈率:-4.78
高:14.02
開:13.69
低:12.94
收:13.49
52周最高:16.93
52周最低:6.47
股本:5,524.42萬
流通股本:4,201.62萬
量比:0.86
換手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-2.7580
每股收益(LYR):-2.4200
淨資產收益率:-43.25%
總資產收益率:-25.09%
市淨率:1.78
市盈率(LYR):-5.44

資料載入中...

2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/20

重要事件披露

Form 8-K - Current report
2026/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

SEC問詢函

Form CORRESP - Correspondence